Thomas Bures
2022
In 2022, Thomas Bures earned a total compensation of $944.2K as Senior Vice President and Chief Financial Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $106,708 |
|---|---|
| Option Awards | $444,183 |
| Salary | $381,100 |
| Other | $12,200 |
| Total | $944,191 |
Bures received $444.2K in option awards, accounting for 47% of the total pay in 2022.
Bures also received $106.7K in non-equity incentive plan, $381.1K in salary and $12.2K in other compensation.
Rankings
In 2022, Thomas Bures' compensation ranked 3,161st out of 5,760 executives tracked by ExecPay. In other words, Bures earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,161 out of 5,760 | 45th |
Division Manufacturing | 1,775 out of 3,136 | 43rd |
Major group Chemicals And Allied Products | 838 out of 1,422 | 41st |
Industry group Drugs | 782 out of 1,323 | 41st |
Industry Pharmaceutical Preparations | 570 out of 969 | 41st |
Source: SEC filing on November 6, 2024.
Bures' colleagues
We found one more compensation record of an executive who worked with Thomas Bures at Pieris Pharmaceuticals in 2022.
2022
Stephen Yoder
Pieris Pharmaceuticals